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Dynamic Contrast Enhanced Magnetic
Resonance Imaging of Diffuse Spinal
Bone Marrow Infiltration in Patients with
Hematological Malignancies
Objective: To investigate the significance of the dynamic contrast enhanced
magnetic resonance imaging (DCE-MRI) parameters of diffuse spinal bone mar-
row infiltration in patients with hematological malignancies. 
Materials and Methods: Dynamic gadolinium-enhanced MR imaging of the
lumbar spine was performed in 26 patients with histologically proven diffuse bone
marrow infiltration, including multiple myeloma (n = 6), acute lymphoblastic
leukemia (n = 6), acute myeloid leukemia (n = 5), chronic myeloid leukemia (n =
7), and non-Hodgkin lymphoma (n = 2). Twenty subjects whose spinal MRI was
normal, made up the control group. Peak enhancement percentage (Emax),
enhancement slope (ES), and time to peak (TTP) were determined from a time-
intensity curve (TIC) of lumbar vertebral bone marrow. A comparison between
baseline and follow-up MR images and its histological correlation were evaluated
in 10 patients. The infiltration grade of hematopoietic marrow with plasma cells
was evaluated by a histological assessment of bone marrow.
Results: Differences in Emax, ES, and TTP values between the control group
and the patients with diffuse bone marrow infiltration were significant (t  = -11.51,
-9.81 and 3.91, respectively, p < 0.01). Emax, ES, and TTP values were signifi-
cantly different between bone marrow infiltration groups Grade 1 and Grade 2 (Z
= -2.72, -2.24 and -2.89 respectively, p < 0.05). Emax, ES and TTP values were
not significantly different between bone marrow infiltration groups Grade 2 and
Grade 3 (Z = -1.57, -1.82 and -1.58 respectively, p > 0.05). A positive correlation
was found between Emax, ES values and the histological grade of bone marrow
infiltration (r = 0.86 and 0.84 respectively, p < 0.01). A negative correlation was
found between the TTP values and bone marrow infiltration histological grade (r =
-0.54, p < 0.01). A decrease in the Emax and ES values was observed with
increased TTP values after treatment in all of the 10 patients who responded to
treatment (t  = -7.92, -4.55, and 5.12, respectively, p < 0.01). 
Conclusion: DCE-MRI of spine can be a useful tool in detecting diffuse mar-
row infiltration of hematological malignancies, while its parameters including
Emax, ES, and TTP can reflect the malignancies’ histological grade.
atients with hematological malignancies such as multiple myeloma,
lymphoma, and leukemia, frequently undergo the replacement of spinal
hemopoietic bone marrow. Focal nodular bone marrow involvement of
the spine in malignant diseases and the use of contrast media has been the subject of
previous magnetic resonance (MR) studies (1-3). However, in early diffuse bone
marrow infiltration, tumor cells do not displace enough bone marrow fat cells, hence
the amount remains relatively normal. The appearance of spinal bone marrow on T1-
and T2-weighted spin-echo MR images is often normal in patients with early diffuse
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is even normal in up to one-quarter of patients with stage
III multiple myeloma (3).
Highly cellular hematopoietic marrow cannot be distin-
guished reliably from highly cellular neoplastic infiltration
by using routine gadopentetate enhanced scans. Recently,
dynamic contrast-enhanced MR imaging (DCE-MRI) based
on time-intensity curves (TIC), which depicts the normal
physiological features of the microcirculation, has been
successfully used in the patients with lymphoproliferative
diseases, diffuse bone marrow infiltration, and in the
assessment of response to chemotherapy (4-9). However,
there have been few studies evaluating DCE-MRI parame-
ters in cases of spinal bone marrow infiltration (6). Thus,
the purpose of this study was to investigate the value of
DCE-MRI parameters of diffuse spinal bone marrow
infiltration in patients with hematological malignancies.
MATERIALS AND METHODS
Subjects
The study was approved by our Institutional Review
Board. Subjects were enrolled from a 558-patient database
that received a routine spinal MRI examination in our
hospital from April 2007 to August 2008. All subjects gave
written informed consent before any examination. 
According to this database, we prospectively enrolled
the only 26 consecutive patients, among the 558 patients,
who fulfilled the following criteria: (a) histologically
proven bone marrow infiltration and (b) no focal or
combined focal and diffuse bone marrow abnormalities at
MR imaging.
Among the 26 patients, six had multiple myeloma (6
males, age range: 56-75 years, mean age: 68.3 years), six
patients had acute lymphoblastic leukemia (2 females, 4
males, age range: 15-79 years, mean age: 44.8 years), five
patients had acute myeloid leukemia (3 females, 2 males,
age range: 12-69 years, mean age: 49.0 years), seven
patients had chronic myeloid leukemia (3 females, 4 males,
age range: 12-66 years, mean age: 45.5 years), and two
patients had diffuse large B-cells non-Hodgkin lymphoma
(NHL) (2 males, 25 years and 41 years, respectively).
Twenty subjects (5 females, 15 males, age range: 41-61
years, mean age: 52.1 years) whose spinal MRI was
normal, made up the control group. These healthy subjects
did not have bone marrow disease, underlying malignancy,
or a recent episode of trauma.
The routine MRI sequences and dynamic study for 26
patients and 12 healthy subjects were performed within a
1-hour interval.
MR Imaging
An MRI examination of the thoracolumbar spine area
was performed approximately 1-3 days prior to the bone
marrow biopsy. All of the patients underwent MR imaging
with a 1.5-Tesla superconducting system and Synergy
spine coil (Gyroscan Intera, Philips Medical System, The
Netherlands). The MR imaging protocol was identical for
all of the patients: T1-weighted spin-echo sequences with a
TR of 480 msec, TE of 11 msec, and T2-weighted turbo
spin-echo sequences with a TR of 3000 msec, and a TE of
120 msec. These sequences were performed with the
following parameters: 256×512 matrix, 33-cm field of
view, and sagittal 4-mm-thickness contiguous sections with
an interval of 0.4 mm.
Dynamic studies of gadolinium enhancement were
performed with a T1-weighted turbo field echo (TFE)
sequence using following parameters: 6.4/3.8 (repetition
time msec/echo time msec), a 30� flip angle, a 224×224
matrix, an acquisition time of 1,000 msec, a 35-cm field of
view, and a midsagittal, 10-mm section thickness. A bolus
of gadopentetate dimeglumine (Magnevist, Schering,
Berlin, Germany; 0.1 mmol/kg body weight) was rapidly
injected with a power injector at a rate of approximately 3
ml/s using a 21-gauge intravenous catheter through the
right antecubital vein. This was followed by a 20-ml saline
flush at the same injection rate. The dynamic imaging was
initiated 5 seconds before injection of the contrast medium.
In total, 100 dynamic images were obtained within 100
seconds (0.98 second per frame) in each patient. The post-
contrast T1-weighted spin-echo sequence was begun 3-5
minutes after the end of the bolus injection of gadoterate
meglumine.
A post treatment DCE-MRI was performed in 12
patients; one with multiple myeloma, four with acute
lymphoblastic leukemia, three with acute myeloid
leukemia, and four with chronic myeloid leukemia after an
interval of 4-6 months.
Qualitative Analysis
Bone marrow signal intensity was analyzed qualitatively
by consensus between two radiologists. By comparing the
signal intensity of the bone marrow with the signal
intensity of adjacent muscle tissue depicted on sagittal T1-
weighted spin-echo MR images, two radiologists defined
the change in signal intensity in terms of low signal
intensity (i.e., lower than the signal intensity of muscle),
iso-signal intensity (i.e., similar to the signal intensity of
muscle) and high signal intensity (i.e., higher than the
signal intensity of muscle). 
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Signal intensity (SI) values were measured in operator-
defined regions of interest (ROIs) in the same vertebral
body (mostly L3 or L4) for perfusion analysis. The regions
of interest were placed centrally and anteriorly in the
vertebral body to avoid the end plates, possible disk
degeneration, and to avoid the basivertebral venous plexus
and cerebrospinal fluid.
The SI values derived from the ROIs were plotted
against time as a TIC using the Gyroview software package
(Gyroscan Intera, Philips Medical Systems, The
Netherlands). The baseline value for signal intensity (SIbase)
in a TIC was defined as the mean SI from the first three
images. The maximum signal intensity (SImax) was defined
as the peak enhancement value for the first pass of contrast
injection. The contrast rise time (Trise) was defined as the
rise time interval from the time point of SIbase to that of
SImax. The contrast time to peak (TTP) enhancement was
defined as the time point of SImax.
The peak enhancement percentage of (Emax) of the
lumbar vertebral and enhancement slope (ES) was used as
an index for lumbar vertebral bone marrow perfusion.
These perfusion indices were calculated as:
Emax = (SImax-SIbase) / SIbase ×100%
ES = (SImax-SIbase) / (SIbase×Trise) ×100%
The above analysis was assessed quantitatively by one
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Fig. 1. 25-year-old man with acute lymphoblastic leukemia.
A. Precontrast T1-weighted spin-echo image of lumbar spine shows no signal intensity changes, however dynamic contrast-enhanced
MRI perfusion imaging of TFE-T1 weighted image obtained at 20 sec, 40 sec and 60 sec after gadopentetate dimeglumine bolus
injection shows enhancement of vertebral bone marrow (Emax = 256.12%, ES = 10.68% and TTP = 20 sec). 
B. L4 vertebral body of same patient shows TIC with initial rapidly rising slope, followed by second slow rising phase.
C. Bone marrow biopsy image of same patient with acute lymphoblastic leukemia shows severe tumor cell infiltration (Hematoxylin &
Eosin staining, ×200). 
D. Decreased Emax and ES values with increased TTP values (Emax = 192.56%, ES = 7.56% and TTP = 25 sec) were observed after
treatment in same patient who responded well to treatment.
TFE = turbo field echo, Emax = peak enhancement percentage, ES = enhancement slope, TTP = time to peak, TIC = time-intensity curve 
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Histological Grading of Tumor Infiltration
The bone marrow biopsies were obtained by a standard
technique (trephine, aspirate or a combination of both)
from the posterior iliac crest. The biopsies were
dehydrated and embedded in methyl methacrylate without
decalcification. Next, semi thin sections of 2μ m were
obtained and subsequently stained with Hematoxylin and
Eosin (HE). Bone marrow infiltration was graded according
to the percentage of neoplastic cells in the bone marrow
samples (Vol%): Grade 0, less than 5% of the non-fat cells
were occupied by tumor cells; Grade 1, 5-25% of the non-
fat cells were occupied by tumor cells; Grade 2, 25-75% of
the non-fat cells were occupied by tumor cells; and Grade
3, more than 75% of the non-fat cells were occupied by
tumor cells. Grades 0 and 1 were considered to represent
none or mild tumor infiltration, at complete or near
complete remission, respectively. Whereas, Grades 2 and 3
were considered to be intermediate and extensive tumor
infiltration, respectively. 
Statistical Analysis
Descriptive statistical data were expressed as the means
± standard deviation. An independent sample t-test was
performed to analyze the statistical significance of
perfusion parameters between the infiltration and control
group. The Mann-Whitney U test was performed to
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Fig. 2. 50-year-old patient with acute myeloid leukemia. 
A. Pre-contrast T1-weighted spin-echo image of lumbar spine shows diffuse low signal intensity consistent with bone marrow infiltration.
Dynamic contrast-enhanced MRI perfusion imaging of TFE-T1 weighted image obtained at 20 sec, 40 sec and 60 sec after gadopente-
tate dimeglumine bolus injection shows enhancement in vertebral bone marrow (Emax = 225.58%, ES = 10.74% and TTP = 22 sec). 
B. L3 vertebral body of same patient shows TIC with rapidly rising slope (wash-in) during initial short period. 
C. Bone marrow biopsy image of same patient (Fig. 3) with acute myeloid leukemia shows moderate tumor cell infiltration (Hematoxylin &
Eosin staining, ×400). 
D. Decreased Emax and ES values with increased TTP values (Emax = 135.35%, ES = 5.12% and TTP = 26.5 sec) were observed after
treatment in same patient who responded well to treatment.
TFE = turbo field echo, Emax = peak enhancement percentage, ES = enhancement slope, TTP = time to peak, TIC = time-intensity curve 
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among different histological grading. A Spearman coeffi-
cient (r) correlation was performed between infiltration
degree and perfusion parameters. A paired sample t-test
was performed to analyze the statistical significance of
perfusion parameters at pre- and post-chemotherapy
treatment MR imaging. A two-sided p value of 0.05 or less
was considered statistically significant. The various statisti-
cal testing was performed using the SPSS 10.0 software
package (SPSS Inc., Chicago, IL).
RESULTS
Bone marrow biopsies showed a Grade 1 infiltration in
three patients with acute lymphoblastic leukemia and three
patients with acute myeloid leukemia, a Grade 2 infiltra-
tion in one patient with acute lymphoblastic leukemia, two
patients with acute myeloid leukemia, two patients with
chronic myeloid leukemia, and one patient with multiple
myeloma, a Grade 3 infiltration in two patients with acute
lymphoblastic leukemia, five patients with chronic myeloid
leukemia, five patients with multiple myeloma, and two
patients with diffuse large B-cells non-Hodgkin lymphoma. 
No obvious abnormality was observed in the lumbar
bone marrow on the sagittal T1-weighted spin-echo images
of three patients with acute lymphoblastic leukemia and
three patients with acute myeloid leukemia (Fig. 1). A
sagittal T1-weighted spin-echo image revealed diffuse
homogeneous low signal intensity in three patients with
acute lymphoblastic leukemia, two patients with acute
myeloid leukemia, seven patients with chronic myeloid
leukemia, one patient with multiple myeloma, and two
patients with diffuse large B-cell non-Hodgkin lymphoma
(Fig. 2). A heterogeneous signal with mixed areas of low
and high signal intensity, described as a pepper and salt
sign, was found in five patients with multiple myeloma.
The differences in Emax, ES, and TTP values between the
control group and the patients with diffuse bone marrow
infiltration were significant (t = -11.51, -9.81 and 3.91,
respectively, p < 0.01). The mean Emax, ES and TTP values
were 260% (± 31.3%), 11% (± 2.8%), and 24.67 (±
2.99) for the malignant infiltration group, 94% (± 64%),
3% (± 2.6%), and 33.44 (± 10.96) for the normal control
group, respectively (Fig. 3). Differences in Emax, ES, and
TTP values between the Grade 1 and Grade 2 infiltration
group were significant (Z = -2.72, -2.24 and -2.89, respec-
tively, p < 0.05). The differences in the Emax, ES, and TTP
values between the Grade 1 and Grade 3 infiltration group
were also significant (Z = -2.72, -2.97 and -2.85, respec-
tively, p < 0.01). However, the differences in Emax, ES, and
TTP values between the Grade 2 and Grade 3 infiltration
group were not significant (Z = -1.57, -1.82 and -1.58,
respectively, p > 0.05) (Table 1). A positive correlation
was found between the Emax, ES values and the bone
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Fig. 3. 35-year-old man in normal control group. 
A. Dynamic contrast-enhanced MRI perfusion imaging of TFE-T1 weighted image obtained at 10 sec, 30 sec and 50 sec after gadopen-
tetate dimeglumine bolus injection shows enhancement in vertebral bone marrow (Emax = 116.42%, ES = 4.67% and TTP = 30.5 sec). 
B. Vertebral body of L4 of same patient shows TIC with initial slowly rising slope followed by platform phase.
TFE = turbo field echo, Emax = peak enhancement percentage, ES = enhancement slope, TTP = time to peak, TIC = time-intensity curve 
A B
Table 1.Comparison of DCE-MRI Parameters among
Different Histological Grades of Infiltration
Emax (%) ES (%) TTP (s)
Grade 1 (n = 6) 230 ± 8.400 8 ± 0.7 28 ± 1.4
Grade 2 (n = 6) 255 ± 16.1 10 ± 1.1 25 ± 0.7
Grade 3 (n = 14) 274 ± 33.4 12 ± 3.1 23 ± 3.0
Control group 094 ± 14.3 03 ± 2.6 33 ± 2.0
P value* < 0.05 < 0.05 < 0.05
Note.─ DCE-MRI = dynamic contrast enhanced magnetic resonance 
imaging, ES = enhancement slope, TTP = time to peak
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0.86 and 0.84, respectively, p < 0.01). A negative correla-
tion was found between the TTP values and the histologi-
cal grade of bone marrow infiltration (r = -0.54, p < 0.01).
A comparison of the signal intensities of the vertebral
bone marrow before and after the application of contrast
agent revealed no significant differences for the sagittal
Gadolinium-enhanced T1-weighted spin-echo sequence in
the control group. Compared to pre-enhanced T1-weighted
imaging, post-enhanced T1-weighted imaging showed no
obvious enhancement of vertebral bone marrow in six
patients, diffuse homogeneous enhancement in 15 patients,
and inhomogeneous enhancement in five patients.
During follow-up observation, bone marrow biopsies
were not performed in one patient with multiple myeloma
and one patient with chronic myeloid leukemia. A
decrease in the Emax and ES values with a corresponding
increase in the TTP values was observed after treatment in
the other 10 patients who positively responded to the
treatment (t = -7.92, -4.55 and 5.12, respectively, p <
0.01) (Table 2). Gadolinium-enhanced sagittal T1-weighted
imaging showed a pronounced reduction of contrast
enhancement after therapy in those patients. The
corresponding change in the post treatment histologic
grades improved from Grade 3 to Grade 1 in all 10
patients.
DISCUSSION
For hematological malignancies, the diffuse infiltration of
bone marrow typically occurs in axial skeleton, such as
skull, spine, sternum, and pelvis. It is difficult to distinguish
diffuse tumor infiltration from the highly variable appear-
ance of normal bone marrow, due to the effects of age and
sex for routine MRI sequences. Various MR imaging
techniques have been developed to improve the detection
and quantification of diffuse bone marrow infiltration.
These techniques include chemical-shift imaging, fat
suppression imaging, bulk T1 relaxation time measure-
ment, and proton MR spectroscopy. However, these
quantitative methods have failed to help in improving the
MR imaging-based detection of diffuse bone marrow
infiltration (6). 
Progression of hematological malignancies is accompa-
nied by an increase in bone marrow neovascularization,
owing to the increased angiogenic potential of bone
marrow tumor cells. Evidence for an increase in angiogene-
sis in hematological malignancies originated from the
expression of angiogenic cytokines, infiltration of metallo-
proteinases, and an increase in blood vessel density in the
angiogenic process (8). In contrast to the histological
detection of microvessel density, DCE-MRI has the
advantage of being functionally variable and providing the
opportunity for subsequent examinations including a much
larger area of investigation (10). DCE-MRI is based up on
an open two-compartment model and has become increas-
ingly important for estimating tissue physiological parame-
ters such as perfusion, capillary permeability, and the
relative volume of extravascular extracellular space. The
Emax has been regarded as a complex process, including
blood inflow, outflow, transit, and permeability factors that
affect extracellular compartment gadolinium concentra-
tion. This parameter indicates the concentration of contrast
material in the extracellular space of the vertebral bone
marrow (11). The enhancement slope is mainly determined
on the basis of tissue vascularization; that is, the number of
vessels, the degree of perfusion, and capillary permeability.
DCE-MRI has been used to correlate dynamic MRI
features with prognostic factors in solid tumor, such as
breast cancer (12). Recent studies have shown that DCE-
MRI can distinguish between normal and malignant spinal
bone marrow infiltration (4, 6). Furthermore, DCE-MRI
may identify malignant bone marrow infiltration in
patients with negative static MRI and serve both as a
diagnostic and prognostic tool for patients with spinal bone
marrow malignancies (7). Other data also demonstrated
that DCE-MRI provided independent evidence for
angiogenesis in multiple myelomas (8). Our results showed
that differences in Emax, ES and TTP values between the
control group and the patients with diffuse bone marrow
infiltration were significant, which implied that DCE-MRI
parameters can reflect the perfusion of spinal bone marrow
infiltration and demonstrate the grades of diffuse bone
marrow infiltration in hematological malignancies. 
It is important to identify bone marrow infiltration
grades in patients with hematological malignancies for
evaluating the clinical staging and treatment response. A
previous study has reported that significant differences in
Emax, slope, and washout were found between subjects
with normal bone marrow and patients with diffuse bone
Zha et al.
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Table 2. Post-Treatment Follow-Up DCE-MRI Parameters in
10 Patients with Good Histological Response
Emax (%) ES (%) TTP (s)
Pre-treatment
261 ± 45.2 11 ± 4.2 23 ± 2.3
(n = 10)
Post-treatment 
127 ± 39.3 07 ± 2.6 28 ± 2.0
(n = 10)
P value < 0.01 < 0.01 < 0.01
Note.─ DCE-MRI = dynamic contrast enhanced magnetic resonance 
imaging, ES = enhancement slope, TTP = time to peakmarrow infiltration. Emax, slope, and washout values
increased with increasing bone marrow infiltration grade
(6). Our results indicated that a positive correlation was
found between Emax, ES values, and histological grade of
bone marrow infiltration. Meanwhile, a negative correla-
tion was found between the TTP values and histological
grade of diffuse bone marrow infiltration. Thus, DCE-MRI
may be helpful in the diagnosis and grading of diffuse
spinal bone marrow infiltration. However the differences
in Emax, ES and TTP values between patients in infiltration
groups Grade 2 and Grade 3 infiltration group were not
significant. We presume that an increasing contribution
and the exudation of gadopentetate dimeglumine in
extracellular space are mainly due to an increase in bone
marrow microvessel permeability and decreased
membrane integrity in patients with Grade 2 and Grade 3
bone marrow infiltration. Consequently, compared to
patients a Grade 1, an extracellular contrast agent is more
rapidly cleared from the intravascular space, and the
equilibrium in the extracellular space is attained more
rapidly for patients with both Grade 2 and Grade 3 bone
marrow infiltration. In addition, our results are preliminary
since the number of patients with Grade 1 or Grade 2 is
relatively small. Further study of tumor angiogenesis in the
specimens is recommended to clarify this issue.
The initial results of a clinical histological study involving
patients with multiple myelomas revealed that after
chemotherapy, the mean microvessel density was signifi-
cantly reduced in responders compared with non-respon-
ders (9, 10). As mentioned above, our results also showed
a decrease in the Emax and ES values with a corresponding
increase in the TTP values after treatment of patients with
hematological malignancies among patients responding
well to treatment. This finding implies that DCE-MRI could
be used to monitor bone marrow perfusion in the follow-
up of patients receiving antiangiogenic therapy. 
This study had several limitations. First, the histological
specimen in the case studies was obtained at the posterior
iliac crest and not in the vertebral body, which implies that
the sites of the biopsies and MRI measurements did not
match. It is not practical to perform routinely vertebral
biopsies in order to identify the histological bone marrow
infiltration grades in these patients. So far, there has been
no evidence of anatomic differences for diffuse infiltration
between the spinal and iliac crest bone marrow in patients
with hematological malignancies. We believe that iliac
bone marrow biopsies are still an accurate and sensitive
method for evaluating the tumor cells burden of bone
marrow. Second, although our preliminary study results
show decreased Emax, ES values and corresponding
increased TTP values after treatment in 10 patients with
hematological malignancies who responded well to
treatment, we acknowledge that the number of patients
followed up with MR imaging were limited. Third, a
previous study showed Emax and wash-out values of
normal spinal bone marrow were significantly higher in
patients younger than 40 years than in those aged 40 years
or older (13). In patients younger than 40 years, spinal
bone marrow consists of bulk hematopoietic red marrow
with a rich vessel network. Further studies will be needed
in order to define the real difference in Emax and ES values
between Grade 1 infiltration and the normal spinal bone
marrow in subjects younger than 40 years.
In conclusion, dynamic contrast-enhanced MR imaging of
the spine can demonstrate diffuse bone marrow infiltration
of hematological malignancies, whereas the DCE-MRI
parameters can reflect histological grade of bone marrow
infiltration.
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